Exodus Point Capital Management, LP Novartis Ag Transaction History

Exodus Point Capital Management, LP

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$92.57 - $107.37 $11.1 Million - $12.9 Million	120,170 New	120,170 $12.8 Million
Q2 2023 Aug 10, 2023	SELL	$92.52 - $104.91 $8.97 Million - $10.2 Million	-96,940 Reduced 56.79%	73,754 $7.44 Million
Q1 2023 May 11, 2023	BUY	$80.03 - $92.81 $13.7 Million - $15.8 Million	170,694 New	170,694 $15.7 Million
Q3 2022 Nov 10, 2022	BUY	$74.61 - $87.26 $7.67 Million - $8.97 Million	102,783 Added 1722.24%	108,751 $8.27 Million
Q2 2022 Aug 19, 2022	BUY	$80.52 - $93.75 $480,543 - $559,500	5,968 New	5,968 $504,000
Q1 2022 May 13, 2022	SELL	$80.11 - $90.62 $551,156 - $623,465	-6,880 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$79.7 - $88.13 $548,336 - $606,334	6,880 New	6,880 $602,000
Q4 2020 Feb 16, 2021	SELL	$78.07 - $94.43 $1.27 Million - $1.54 Million	-16,297 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$82.14 - $91.0 $1.34 Million - $1.48 Million	16,297 New	16,297 $1.42 Million
Q2 2020 Aug 14, 2020	SELL	$80.93 - $91.1 $206,047 - $231,940	-2,546 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$70.67 - $99.01 $985,917 - $1.38 Million	-13,951 Reduced 84.57%	2,546 $210,000
Q4 2019 Feb 14, 2020	BUY	$84.35 - $95.37 $573,073 - $647,943	6,794 Added 70.02%	16,497 $1.56 Million
Q3 2019 Nov 14, 2019	BUY	$85.54 - $94.26 $829,994 - $914,604	9,703 New	9,703 $843,000
Q1 2019 May 15, 2019	SELL	$75.32 - $86.15 $213,004 - $243,632	-2,828 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$73.66 - $82.02 $208,310 - $231,952	2,828 New	2,828 $243,000

1,437

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $223B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.